Cargando…
A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer
Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107037/ https://www.ncbi.nlm.nih.gov/pubmed/35578667 http://dx.doi.org/10.1155/2022/3143511 |
_version_ | 1784708403197640704 |
---|---|
author | Zhang, Xin Zhang, Xingda Li, Guozheng Hao, Yi Liu, Lei Zhang, Lei Chen, Yihai Wu, Jiale Wang, Xinheng Yang, Shuai Xu, Shouping |
author_facet | Zhang, Xin Zhang, Xingda Li, Guozheng Hao, Yi Liu, Lei Zhang, Lei Chen, Yihai Wu, Jiale Wang, Xinheng Yang, Shuai Xu, Shouping |
author_sort | Zhang, Xin |
collection | PubMed |
description | Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between necroptosis-associated lncRNAs and BRCA. In this study, we established a signature basis of 7 necroptosis-related lncRNAs associated with prognosis and divided BRCA patients into high- and low-risk groups. Kaplan-Meier curves all showed an adverse prognosis for patients in the high-risk group. Cox assays confirmed that risk score was an independent prognostic factor for BRCA patients. The receiver operating characteristic (ROC) curve proved the predictive accuracy of the signature and the area under the curve (AUC) values of the risk score reached 0.722. The nomogram relatively accurately predicted the prognosis of the patients. GSEA analysis suggested that the related signaling pathways and biological processes enriched in the high- and low-risk groups may influence the tumor microenvironment (TME) of BRCA. ssGSEA showed the difference in immune cell infiltration, immune pathway activation, and immune checkpoint expression between the two risk groups, with the low-risk group more suitable for immunotherapy. According to the significant difference in IC50 between risk groups, patients can be guided for an individualized treatment plan. Overall, the authors established a prognostic signature consisting of 7 necroptosis-associated lncRNAs that can independently predict the clinical outcome of BRCA patients. The difference in the tumor immune microenvironment between the low- and high-risk populations may be the reason for the resistance to immunotherapy in some patients. |
format | Online Article Text |
id | pubmed-9107037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-91070372022-05-15 A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer Zhang, Xin Zhang, Xingda Li, Guozheng Hao, Yi Liu, Lei Zhang, Lei Chen, Yihai Wu, Jiale Wang, Xinheng Yang, Shuai Xu, Shouping J Immunol Res Research Article Breast cancer (BRCA) is one of the leading causes of death among women worldwide, and drug resistance often leads to a poor prognosis. Necroptosis is a type of programmed cell death (PCD) and exhibits regulatory effects on tumor progression, but few studies have focused on the relationships between necroptosis-associated lncRNAs and BRCA. In this study, we established a signature basis of 7 necroptosis-related lncRNAs associated with prognosis and divided BRCA patients into high- and low-risk groups. Kaplan-Meier curves all showed an adverse prognosis for patients in the high-risk group. Cox assays confirmed that risk score was an independent prognostic factor for BRCA patients. The receiver operating characteristic (ROC) curve proved the predictive accuracy of the signature and the area under the curve (AUC) values of the risk score reached 0.722. The nomogram relatively accurately predicted the prognosis of the patients. GSEA analysis suggested that the related signaling pathways and biological processes enriched in the high- and low-risk groups may influence the tumor microenvironment (TME) of BRCA. ssGSEA showed the difference in immune cell infiltration, immune pathway activation, and immune checkpoint expression between the two risk groups, with the low-risk group more suitable for immunotherapy. According to the significant difference in IC50 between risk groups, patients can be guided for an individualized treatment plan. Overall, the authors established a prognostic signature consisting of 7 necroptosis-associated lncRNAs that can independently predict the clinical outcome of BRCA patients. The difference in the tumor immune microenvironment between the low- and high-risk populations may be the reason for the resistance to immunotherapy in some patients. Hindawi 2022-05-05 /pmc/articles/PMC9107037/ /pubmed/35578667 http://dx.doi.org/10.1155/2022/3143511 Text en Copyright © 2022 Xin Zhang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Zhang, Xin Zhang, Xingda Li, Guozheng Hao, Yi Liu, Lei Zhang, Lei Chen, Yihai Wu, Jiale Wang, Xinheng Yang, Shuai Xu, Shouping A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title | A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title_full | A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title_fullStr | A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title_full_unstemmed | A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title_short | A Novel Necroptosis-Associated lncRNA Signature Can Impact the Immune Status and Predict the Outcome of Breast Cancer |
title_sort | novel necroptosis-associated lncrna signature can impact the immune status and predict the outcome of breast cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107037/ https://www.ncbi.nlm.nih.gov/pubmed/35578667 http://dx.doi.org/10.1155/2022/3143511 |
work_keys_str_mv | AT zhangxin anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT zhangxingda anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT liguozheng anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT haoyi anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT liulei anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT zhanglei anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT chenyihai anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT wujiale anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT wangxinheng anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT yangshuai anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT xushouping anovelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT zhangxin novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT zhangxingda novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT liguozheng novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT haoyi novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT liulei novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT zhanglei novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT chenyihai novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT wujiale novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT wangxinheng novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT yangshuai novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer AT xushouping novelnecroptosisassociatedlncrnasignaturecanimpacttheimmunestatusandpredicttheoutcomeofbreastcancer |